Interleukin Inhibitors May Raise Infection, Cancer Risks

Treatment of rheumatologic diseases with interleukin inhibitors may raise patients’ risks for serious and opportunistic infections and possibly also cancer, researchers reported in JAMA Network Open in October.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *